How many insider trades does FilingIQ track for SYBX?

FilingIQ tracks 71 Form 4 insider transactions for SYBX (SYNLOGIC, INC.), covering filings from Aug 28, 2017 onwards. 2 of those were filed in the last 90 days.

Are SYBX insiders net buyers or net sellers?

Across the full Form 4 history for SYBX, 3 transactions (4%) were open-market purchases and 22 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SYBX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SYBX in?

SYNLOGIC, INC. (SYBX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $7.22M.

SYBX insider trading

OTC Markets OTCPK Healthcare

SYNLOGIC, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

4% / 31%

Market cap

$7.22M

About SYNLOGIC, INC.

Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Winchester, Massachusetts.

Company website: www.synlogictx.com

SYBX insider activity at a glance

FilingIQ has scored 71 insider transactions for SYBX since Aug 28, 2017. The most recent filing in our index is dated Jul 27, 2026.

Across the full history, 3 open-market purchases and 22 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SYBX insider trades is 54.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SYBX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for SYBX?: FilingIQ tracks 71 Form 4 insider transactions for SYBX (SYNLOGIC, INC.), covering filings from Aug 28, 2017 onwards. 2 of those were filed in the last 90 days.
Are SYBX insiders net buyers or net sellers?: Across the full Form 4 history for SYBX, 3 transactions (4%) were open-market purchases and 22 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SYBX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SYBX in?: SYNLOGIC, INC. (SYBX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $7.22M.

Methodology & sources

Every SYBX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.